About Us

Wilmington PharmaTech Company LLC is a leading global service company specializing in the research and development of chemical process and medicinal chemistry for the pharmaceutical and biotechnology industries. Founded in 2003, WPT has a track record of reliable and quality services for pharma and biotech companies worldwide with the state of art facilities and operations in the United States and China. Based on the established expertise and proprietary technologies, WPT has developed a wide range of capabilities for the research and development of today’s medicines, including custom synthesis, process chemistry, medicinal chemistry, API manufacturing, FTE research, polymorph screening and salt selection, and analytical services.

cGMP Synthesis, FTE Contract Research, Polymorph Screening and Salt Selection, Analytical GLP and GMP Services, Genotoxic Impurity Trace Analysis, Stable Isotope Labeling, Drug Reference Standards, Biotransformation, Chiral Resolution, Asymmetric Catalysis

• February, 2003: Company Started
• May, 2003: DTP Solid State Lab Started
• June, 2004: DTP Large Process Lab Started
• March, 2005: DTP cGMP Kilo Lab Completed
• May, 2007: Leased Pencader, DE Site
• November, 2007: Pencader Process Lab Started
• March, 2008: Pencader Kilo cGMP Lab Started
• August 2009: Pencader Facility Completed.
• October 2009: Headquarters Moved to Pencader Facility
• January 2010: China Suzhou Research Center
• December 2012: Fenghuang Holdings Investment
• 2013: New Pilot Production Facilities in Zhangjiagang, Suzhou
• 2020: New Glasgow facilities with both pilot plant and HPAPI suits in Newark, DE.
https://www.youtube.com/watch?v=o0UX2hRSSws